SDIX Key Stats
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly Report May 15
- Egalet Appoints Stan Musial as CFO PR Newswire May 8
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-K, Annual Report Apr 15
- China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare Apr 14
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Entry into a Material Definiti... Apr 10
- OriGene to Acquire SDIX's Life Science Business Assets PR Newswire Apr 8
- Strategic Diagnostics (SDIX) Will Resume Trading at 9:45am ET Street Insider Apr 8
- SDIX (SDIX) to Sell Life Science Assets in $16M Deal Street Insider Apr 8
- SDIX Sells Life Science Assets to OriGene Technologies, Inc. for $16 Million Business Wire Apr 8
- SDIX trading halted, pending news Apr 8
SDIX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Strategic Diagnostics is down 39.16% over the last year vs S&P 500 Total Return up 29.62%, EntreMed down 8.50%, and ARCA biopharma down 7.58%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for SDIX
Pro Report PDF for SDIX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download SDIX Pro Report PDF
Pro Strategies Featuring SDIX
Did Strategic Diagnostics make it into our Pro Portfolio Strategies?